Age-related Macular Degeneration

Innovative Approaches to Reducing Treatment Burden in Age-related Macular Degeneration and Diabetic Macular Edema

Innovative Approaches to Reducing Treatment Burden in Age-related Macular Degeneration and Diabetic Macular Edema

Less than optimal visual acuity gains in patients with neovascular age-rel…

Expiration Date: 8/4/2022

Max Credits: 0

View Activity

Lengthening the Treatment Interval in Age-related Macular Degeneration: Current Status and Insights

Lengthening the Treatment Interval in Age-related Macular Degeneration: Current Status and Insights

Intravitreal antivascular endothelial growth factor therapy has revolution…

Expiration Date: 6/29/2022

Max Credits: 0

View Activity

Diabetic Macular Edema Management in 2021: What’s New?

Diabetic Macular Edema Management in 2021: What’s New?

Although anti-VEGF therapy has revolutionized the management of diabetic m…

Expiration Date: 6/17/2022

Max Credits: 0

View Activity

Neovascular AMD: Impact of Dosing Regimens and Residual Retinal Fluid on Long-Term Outcomes

Neovascular AMD: Impact of Dosing Regimens and Residual Retinal Fluid on Long-Term Outcomes

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 6/15/2022

Max Credits: 0

View Activity

Curbside Consults: Applying Real World Evidence to Practice When Selecting Treatment for nAMD

Curbside Consults: Applying Real World Evidence to Practice When Selecting Treatment for nAMD

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 5/30/2022

Max Credits: 0

View Activity

Curbside Consults: Residual Retinal Fluid Following Treatment of nAMD

Curbside Consults: Residual Retinal Fluid Following Treatment of nAMD

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 5/30/2022

Max Credits: 0

View Activity

Curbside Consults: Long-term Management of nAMD

Curbside Consults: Long-term Management of nAMD

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 5/30/2022

Max Credits: 0

View Activity

Curbside Consults: Treating nAMD: Getting Past the Burden

Curbside Consults: Treating nAMD: Getting Past the Burden

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 5/30/2022

Max Credits: 0

View Activity

Best of Ophthalmology Research for May 2021: Emerging Approaches in Treatment of nAMD and DME

Best of Ophthalmology Research for May 2021: Emerging Approaches in Treatment of nAMD and DME

The utilization of anti-vascular endothelial growth factor therapy in trea…

Expiration Date: 5/27/2022

Max Credits: 0

View Activity

Branching Out to Reduce the Burden of Treatment in Age-related Macular Degeneration and Diabetic Macular Edema: Novel Approaches

Branching Out to Reduce the Burden of Treatment in Age-related Macular Degeneration and Diabetic Macular Edema: Novel Approaches

Visual acuity gains demonstrated in pinnacle clinical studies for retinal …

Expiration Date: 5/16/2022

Max Credits: 0

View Activity